Bacteriophages pp 183-190 | Cite as

Exploitation of Drosophila Infection Models to Evaluate Antibacterial Efficacy of Phages

  • Hye-Jeong Jang
  • Hee-Won Bae
  • You-Hee ChoEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1898)


Nonmammalian infection models have been exploited to understand the various aspects of host-pathogen interactions and also provided innovative research platforms for identification of virulence factors, screening for antimicrobial hits, and evaluation of antimicroial efficacy. Here we describe a relatively straightforward protocol to assess the antibacterial efficacy of bacteriophages (phages) toward the opportunistic human pathogen, Pseudomonas aeruginosa, based on the systemic infection model using the fruit fly, Drosophila melanogaster. Since phages, unlike antibacterial chemicals, can be easily and sensitively enumerated by simple assays, it is also possible to address the pharmacokinetic properties of administered phages even in this small-scale infection model.

Key words

Small-scale Infection model Drosophila melanogaster Pseudomonas aeruginosa Phage Antibacterial efficacy Pharmacokinetics 



We are grateful to the members of the Cho Lab for their technical assistance and helpful comments. This work was supported by the National Research Foundation of Korea (NRF) Grant (NRF-2017R1A2B3005239).


  1. 1.
    Shirasu-Hiza MM, Schneider DS (2007) Confronting physiology: how do infected flies die? Cell Microbiol 12:2775–2783CrossRefGoogle Scholar
  2. 2.
    Lemaitre B, Hoffmann JA (2007) The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697–743CrossRefGoogle Scholar
  3. 3.
    Hoffmann JA, Reichhart JM (2002) Drosophila innate immunity: an evolutionary perspective. Nat Immunol 2:121–126CrossRefGoogle Scholar
  4. 4.
    D’Argenio DA, Gallagher LA, Berg CA, Manoil C (2001) Drosophila as a model host for Pseudomonas aeruginosa infection. J Bacteriol 183:1466–1471CrossRefGoogle Scholar
  5. 5.
    Lau GW, Goumnerov BC, Walendziewicz CL, Hewitson J, Xiao W, Mahajan-Miklos S, Tompkins RG, Perkins LA, Rahme LG (2003) The Drosophila melanogaster Toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa. Infect Immun 71:4059–4066CrossRefGoogle Scholar
  6. 6.
    Lee J-S, Heo Y-J, Lee JK, Cho Y-H (2005) KatA, the major catalase, is critical for osmoprotection and virulence in Pseudomonas aeruginosa PA14. Infect Immun 73:4399–4403CrossRefGoogle Scholar
  7. 7.
    Kim S-H, Park S-Y, Heo Y-J, Cho Y-H (2008) Drosophila melanogaster-based screening for multihost virulence factors of Pseudomonas aeruginosa PA14 and identification of a virulence-attenuating factor, HudA. Infect Immun 76:4152–4162CrossRefGoogle Scholar
  8. 8.
    Apidianakis Y, Rahme LG (2009) Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection. Nat Protoc 9:1285–1294CrossRefGoogle Scholar
  9. 9.
    Heo Y-J, Lee Y-R, Jung H-H, Lee J, Ko G, Cho Y-H (2009) Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster. Antimicrob Agents Chemother 53:2469–2474CrossRefGoogle Scholar
  10. 10.
    Chung I-Y, Sim N, Cho Y-H (2012) Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities. Antimicrob Agents Chemother 56:5612–5617CrossRefGoogle Scholar
  11. 11.
    Bae H-W (2014) Antibacterial efficacy and host spectrum of a Pseudomonas aeruginosa RNA phage. Ph.D Thesis, Korea: CHA UniversityGoogle Scholar
  12. 12.
    Lee, Y-J, Jang, H-J, Chung, I-Y, and Cho, Y-H (2018) Drosophila melanogaster as a polymicrobial infection model for Pseudomonas aeruginosa and Staphylococcus aureus. J Microbiol 56:534–541.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical SciencesCHA UniversityGyeonggi-doSouth Korea

Personalised recommendations